Boehringer Ingelheim GmbH - SWOT, Strategy and Corporate Finance Report
Published: December 2012 · Publisher: MarketLine
Boehringer Ingelheim GmbH - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Boehringer Ingelheim GmbH - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis
- An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Boehringer Ingelheim GmbH
- Intelligence on Boehringer Ingelheim GmbHnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Boehringer Ingelheim (BI or 'the group’) is a privately-held pharmaceuticals and animal health business group. BI, through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, and animal health products. The group operates in Europe, the Americas, Asia, Australia and Africa. It is headquartered in Ingelheim, Germany. For 2011, the group’s average number of employees was 44,094. The group recorded revenues of E13,171 million ($18,339.3 million*) during the financial year ended December 2011 (FY2011), an increase of 4.6% over FY2010. The operating profit of the group was E2,272 million ($3,163.5 million*) in FY2011, an increase of 19.8% over FY2010. The net profit was E1,476 million ($2,055.2 million*) in FY2011, an increase of 66.2% over FY2010. *Calculated using a constant conversion rate of E1 = $1.3924 for the year ended December 31, 2011.
Reasons to Purchase:
- Gain understanding of Boehringer Ingelheim GmbH and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Boehringer Ingelheim GmbH as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Boehringer Ingelheim GmbH’s business structure, strategy and prospects
Features:
- Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis
- An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Boehringer Ingelheim GmbH
- Intelligence on Boehringer Ingelheim GmbHnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Boehringer Ingelheim (BI or 'the group’) is a privately-held pharmaceuticals and animal health business group. BI, through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, and animal health products. The group operates in Europe, the Americas, Asia, Australia and Africa. It is headquartered in Ingelheim, Germany. For 2011, the group’s average number of employees was 44,094. The group recorded revenues of E13,171 million ($18,339.3 million*) during the financial year ended December 2011 (FY2011), an increase of 4.6% over FY2010. The operating profit of the group was E2,272 million ($3,163.5 million*) in FY2011, an increase of 19.8% over FY2010. The net profit was E1,476 million ($2,055.2 million*) in FY2011, an increase of 66.2% over FY2010. *Calculated using a constant conversion rate of E1 = $1.3924 for the year ended December 31, 2011.
Reasons to Purchase:
- Gain understanding of Boehringer Ingelheim GmbH and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Boehringer Ingelheim GmbH as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Boehringer Ingelheim GmbH’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Boehringer Ingelheim GmbH: Company Overview
Boehringer Ingelheim GmbH: Overview and Key Facts
Boehringer Ingelheim GmbH: Overview
Boehringer Ingelheim GmbH: Key Facts
Boehringer Ingelheim GmbH: Key Employees
Boehringer Ingelheim GmbH: Major Products and Services
Boehringer Ingelheim GmbH: Company History
Boehringer Ingelheim GmbH: Management Statement
Boehringer Ingelheim GmbH: Locations and Subsidiaries
Boehringer Ingelheim GmbH: Key Competitors
Boehringer Ingelheim GmbH: Company Analysis
Boehringer Ingelheim GmbH: Business Description
Boehringer Ingelheim GmbH: SWOT Analysis
Boehringer Ingelheim GmbH: SWOT Overview
Boehringer Ingelheim GmbH: Strengths
Boehringer Ingelheim GmbH: Weaknesses
Boehringer Ingelheim GmbH: Opportunities
Boehringer Ingelheim GmbH: Threats
Boehringer Ingelheim GmbH: Corporate Financial Deals Activity
Boehringer Ingelheim GmbH: Financial Deals Overview
Boehringer Ingelheim GmbH: Targets and Partners
Boehringer Ingelheim GmbH: Top Deals 2008 - 2012YTD*
Boehringer Ingelheim GmbH: Mergers and Acquisitions
Boehringer Ingelheim GmbH: Partnership
Boehringer Ingelheim GmbH: Recent Developments
Boehringer Ingelheim GmbH: News and Events Summary
Boehringer Ingelheim GmbH: Business Expansion
Boehringer Ingelheim GmbH: Contracts
Boehringer Ingelheim GmbH: Financial Performance
Boehringer Ingelheim GmbH: Regulatory and Legal Events
Boehringer Ingelheim GmbH: Research & Development
Boehringer Ingelheim GmbH: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Boehringer Ingelheim GmbH: Key Facts
Table 2: Boehringer Ingelheim GmbH: Key Employees
Table 4: Boehringer Ingelheim GmbH: Key Competitors
Table 5: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Boehringer Ingelheim GmbH: M&A Activity by Geography (TTM*)
Table 7: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Table 8: Boehringer Ingelheim GmbH: M&A Average Deal Size - Value (US$m)
Table 9: Boehringer Ingelheim GmbH: Targets and Partners
Table 10: Boehringer Ingelheim GmbH: Top Deals 2008 - 2012YTD*
Table 11: Boehringer Ingelheim GmbH: M&A Volume and Value Trend (2008 - YTD*2012)
Table 12: Boehringer Ingelheim GmbH: M&A Activity by Geography (2008 - YTD*2012)
Table 13: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2008 - YTD*2012)
Table 14: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2008 - YTD*2012)
Table 15: Boehringer Ingelheim GmbH: News and Events Summary
Table 16: Boehringer Ingelheim GmbH: Business Expansion
Table 17: Boehringer Ingelheim GmbH: Contracts
Table 18: Boehringer Ingelheim GmbH: Financial Performance
Table 19: Boehringer Ingelheim GmbH: Regulatory and Legal Events
Table 20: Boehringer Ingelheim GmbH: Research & Development
Table 21: Boehringer Ingelheim GmbH: Strategy and Operations
List of Figures
Figure 1: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Boehringer Ingelheim GmbH: M&A Activity by Geography (TTM*)
Figure 3: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Figure 4: Boehringer Ingelheim GmbH: M&A Average Deal Size - Value (US$m)
Figure 5: Boehringer Ingelheim GmbH: M&A Volume and Value Trend (2008 - YTD*2012)
Figure 6: Boehringer Ingelheim GmbH: M&A Activity by Geography (2008 - YTD*2012)
Figure 7: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2008 - YTD*2012)
Figure 8: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2008 - YTD*2012)
Boehringer Ingelheim GmbH: Company Overview
Boehringer Ingelheim GmbH: Overview and Key Facts
Boehringer Ingelheim GmbH: Overview
Boehringer Ingelheim GmbH: Key Facts
Boehringer Ingelheim GmbH: Key Employees
Boehringer Ingelheim GmbH: Major Products and Services
Boehringer Ingelheim GmbH: Company History
Boehringer Ingelheim GmbH: Management Statement
Boehringer Ingelheim GmbH: Locations and Subsidiaries
Boehringer Ingelheim GmbH: Key Competitors
Boehringer Ingelheim GmbH: Company Analysis
Boehringer Ingelheim GmbH: Business Description
Boehringer Ingelheim GmbH: SWOT Analysis
Boehringer Ingelheim GmbH: SWOT Overview
Boehringer Ingelheim GmbH: Strengths
Boehringer Ingelheim GmbH: Weaknesses
Boehringer Ingelheim GmbH: Opportunities
Boehringer Ingelheim GmbH: Threats
Boehringer Ingelheim GmbH: Corporate Financial Deals Activity
Boehringer Ingelheim GmbH: Financial Deals Overview
Boehringer Ingelheim GmbH: Targets and Partners
Boehringer Ingelheim GmbH: Top Deals 2008 - 2012YTD*
Boehringer Ingelheim GmbH: Mergers and Acquisitions
Boehringer Ingelheim GmbH: Partnership
Boehringer Ingelheim GmbH: Recent Developments
Boehringer Ingelheim GmbH: News and Events Summary
Boehringer Ingelheim GmbH: Business Expansion
Boehringer Ingelheim GmbH: Contracts
Boehringer Ingelheim GmbH: Financial Performance
Boehringer Ingelheim GmbH: Regulatory and Legal Events
Boehringer Ingelheim GmbH: Research & Development
Boehringer Ingelheim GmbH: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Boehringer Ingelheim GmbH: Key Facts
Table 2: Boehringer Ingelheim GmbH: Key Employees
Table 4: Boehringer Ingelheim GmbH: Key Competitors
Table 5: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Boehringer Ingelheim GmbH: M&A Activity by Geography (TTM*)
Table 7: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Table 8: Boehringer Ingelheim GmbH: M&A Average Deal Size - Value (US$m)
Table 9: Boehringer Ingelheim GmbH: Targets and Partners
Table 10: Boehringer Ingelheim GmbH: Top Deals 2008 - 2012YTD*
Table 11: Boehringer Ingelheim GmbH: M&A Volume and Value Trend (2008 - YTD*2012)
Table 12: Boehringer Ingelheim GmbH: M&A Activity by Geography (2008 - YTD*2012)
Table 13: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2008 - YTD*2012)
Table 14: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2008 - YTD*2012)
Table 15: Boehringer Ingelheim GmbH: News and Events Summary
Table 16: Boehringer Ingelheim GmbH: Business Expansion
Table 17: Boehringer Ingelheim GmbH: Contracts
Table 18: Boehringer Ingelheim GmbH: Financial Performance
Table 19: Boehringer Ingelheim GmbH: Regulatory and Legal Events
Table 20: Boehringer Ingelheim GmbH: Research & Development
Table 21: Boehringer Ingelheim GmbH: Strategy and Operations
List of Figures
Figure 1: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Boehringer Ingelheim GmbH: M&A Activity by Geography (TTM*)
Figure 3: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Figure 4: Boehringer Ingelheim GmbH: M&A Average Deal Size - Value (US$m)
Figure 5: Boehringer Ingelheim GmbH: M&A Volume and Value Trend (2008 - YTD*2012)
Figure 6: Boehringer Ingelheim GmbH: M&A Activity by Geography (2008 - YTD*2012)
Figure 7: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2008 - YTD*2012)
Figure 8: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2008 - YTD*2012)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.